Skip to Main Content

Paper Details

Uptake of non-statin lipid-lowering therapies for secondary prevention in community practice.
J Clin Lipidol
3
2023
ASCVD, PCSK9i, atherosclerotic cardiovascular disease, cholesterol, ezetimibe, icosapent ethyl, low-density lipoprotein cholesterol, patients, statin, statins, subtilisin/kexin
Author NameAffiliation
Eric D PetersonUniversity of Texas Southwestern Medical Center
Eric D PetersonUniversity of Texas Southwestern Medical Center
Ann Marie NavarUniversity of Texas Southwestern Medical Center
  • 1 - 3

Datasets

Release 1.2